Syon Capital LLC Takes $306,000 Position in MetLife, Inc. (NYSE:MET)

Syon Capital LLC acquired a new stake in shares of MetLife, Inc. (NYSE:METFree Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 4,863 shares of the financial services provider’s stock, valued at approximately $306,000.

A number of other large investors also recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of MetLife in the 4th quarter worth $444,205,000. Franklin Resources Inc. grew its holdings in MetLife by 499.6% during the second quarter. Franklin Resources Inc. now owns 4,073,174 shares of the financial services provider’s stock worth $230,257,000 after acquiring an additional 3,393,875 shares during the period. Moneta Group Investment Advisors LLC acquired a new stake in MetLife during the fourth quarter worth about $234,761,000. Bank Julius Baer & Co. Ltd Zurich grew its holdings in MetLife by 42,754.1% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,766,876 shares of the financial services provider’s stock worth $99,882,000 after acquiring an additional 1,762,753 shares during the period. Finally, Cibc World Markets Corp grew its holdings in MetLife by 1,582.0% during the second quarter. Cibc World Markets Corp now owns 1,456,203 shares of the financial services provider’s stock worth $82,319,000 after acquiring an additional 1,369,627 shares during the period. Hedge funds and other institutional investors own 88.14% of the company’s stock.

MetLife Price Performance

Shares of NYSE:MET traded up $0.49 during trading on Friday, hitting $70.88. 3,386,946 shares of the stock were exchanged, compared to its average volume of 3,794,517. The company has a fifty day moving average price of $66.10 and a two-hundred day moving average price of $63.43. The company has a market cap of $52.46 billion, a PE ratio of 26.06, a P/E/G ratio of 0.70 and a beta of 1.05. The company has a current ratio of 0.13, a quick ratio of 0.13 and a debt-to-equity ratio of 0.62. MetLife, Inc. has a 12-month low of $48.95 and a 12-month high of $73.28.

MetLife (NYSE:METGet Free Report) last posted its earnings results on Wednesday, November 1st. The financial services provider reported $1.97 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.99 by ($0.02). MetLife had a net margin of 3.60% and a return on equity of 19.14%. The company had revenue of $15.87 billion during the quarter, compared to analysts’ expectations of $17.49 billion. During the same period in the previous year, the company posted $1.21 EPS. MetLife’s quarterly revenue was down 28.8% compared to the same quarter last year. On average, analysts forecast that MetLife, Inc. will post 7.37 EPS for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 14th. Stockholders of record on Tuesday, February 6th will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend is Monday, February 5th. MetLife’s dividend payout ratio (DPR) is 76.47%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Barclays reiterated an “overweight” rating and set a $71.00 price target on shares of MetLife in a research report on Friday, November 17th. Deutsche Bank Aktiengesellschaft initiated coverage on MetLife in a research note on Wednesday, October 4th. They issued a “hold” rating and a $71.00 price objective for the company. The Goldman Sachs Group upgraded MetLife from a “neutral” rating to a “buy” rating and lifted their target price for the company from $70.00 to $80.00 in a report on Monday, January 8th. initiated coverage on MetLife in a report on Thursday, October 5th. They issued a “hold” rating for the company. Finally, UBS Group lifted their target price on MetLife from $84.00 to $87.00 and gave the company a “buy” rating in a report on Wednesday, January 10th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $77.62.

View Our Latest Stock Report on MET

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with's FREE daily email newsletter.